lobbying_activities: 1240345

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
1240345	6a159745-801c-4032-a168-f8dcd87ca12b	Q1	EMPIRE CONSULTING GROUP	400703105	PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA	2012	first_quarter	PHA	H.R. 3995, Protecting Consumer Access to Generic Drugs Act; The Prescription Drug User Fee Act ("PDUFA V"); Prescription Drug Abuse; H.R. 452, Medicare Decisions Accountability Act (repealing provisions of healthcare law relating to the Independent Payment Advisory Board/IPAB); S.1002/H.R. 4223, Safe Doses Act; and Biologics Price Competition Act implementation;	HOUSE OF REPRESENTATIVES	30000		0	0	2012-04-19T17:46:13.663000-04:00